BioPharm International-10-15-2018

Providing analytical data on the comparison between a biosimilar and the reference product is a primary consideration in the development of biosimilars.

Experts discuss best practices for performing glycan analysis.

The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality.

This article discusses why it is important to apply risk analysis, QbD, and DoE in the development of analytical methods.

By adapting techniques from other sciences-and exploring better tools for biologics drug development-researchers are addressing challenges of protein characterization.

As biopharma companies rapidly change their focus, they may lack the laboratory space, instrumentation, and the scientific knowledge to support biologics research.